Logo image of BRM.CA

BIOREM INC (BRM.CA) Stock Fundamental Analysis

TSX-V:BRM - TSX Venture Exchange - CA09068G1046 - Common Stock - Currency: CAD

2.37  -0.05 (-2.07%)

Fundamental Rating

7

Taking everything into account, BRM scores 7 out of 10 in our fundamental rating. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. BRM gets an excellent profitability rating and is at the same time showing great financial health properties. BRM scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes BRM very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year BRM was profitable.
In the past year BRM had a positive cash flow from operations.
BRM had positive earnings in each of the past 5 years.
Each year in the past 5 years BRM had a positive operating cash flow.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

With an excellent Return On Assets value of 12.64%, BRM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of 30.95%, BRM belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
BRM has a Return On Invested Capital of 26.24%. This is amongst the best in the industry. BRM outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRM is significantly above the industry average of 7.19%.
The last Return On Invested Capital (26.24%) for BRM is above the 3 year average (25.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.64%
ROE 30.95%
ROIC 26.24%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

BRM has a better Profit Margin (7.31%) than 83.33% of its industry peers.
In the last couple of years the Profit Margin of BRM has grown nicely.
Looking at the Operating Margin, with a value of 10.65%, BRM is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
In the last couple of years the Operating Margin of BRM has grown nicely.
The Gross Margin of BRM (26.49%) is comparable to the rest of the industry.
BRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 7.31%
GM 26.49%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRM is creating value.
BRM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRM has less shares outstanding
The debt/assets ratio for BRM has been reduced compared to a year ago.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

BRM has an Altman-Z score of 4.53. This indicates that BRM is financially healthy and has little risk of bankruptcy at the moment.
BRM has a better Altman-Z score (4.53) than 95.83% of its industry peers.
The Debt to FCF ratio of BRM is 0.91, which is an excellent value as it means it would take BRM, only 0.91 years of fcf income to pay off all of its debts.
BRM has a better Debt to FCF ratio (0.91) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that BRM is not too dependend on debt financing.
BRM has a Debt to Equity ratio of 0.30. This is amongst the best in the industry. BRM outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.91
Altman-Z 4.53
ROIC/WACC3.5
WACC7.49%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.91 indicates that BRM should not have too much problems paying its short term obligations.
The Current ratio of BRM (1.91) is better than 87.50% of its industry peers.
BRM has a Quick Ratio of 1.66. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
BRM has a Quick ratio of 1.66. This is in the better half of the industry: BRM outperforms 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.66
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

The earnings per share for BRM have decreased strongly by -13.75% in the last year.
Measured over the past years, BRM shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.08% on average per year.
BRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.00%.
Measured over the past years, BRM shows a quite strong growth in Revenue. The Revenue has been growing by 12.63% on average per year.
EPS 1Y (TTM)-13.75%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-89.13%
Revenue 1Y (TTM)51%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-20.07%

3.2 Future

The Earnings Per Share is expected to grow by 23.54% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y15.79%
EPS Next 2Y23.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.05%
Revenue Next 2Y8.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.94, the valuation of BRM can be described as correct.
Based on the Price/Earnings ratio, BRM is valued cheaper than 91.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. BRM is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 7.93, the valuation of BRM can be described as very cheap.
BRM's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 87.50% of the companies in the same industry.
BRM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 13.94
Fwd PE 7.93
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 87.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BRM is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.31
EV/EBITDA 7.06
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

BRM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of BRM may justify a higher PE ratio.
A more expensive valuation may be justified as BRM's earnings are expected to grow with 23.54% in the coming years.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y23.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIOREM INC

TSX-V:BRM (7/4/2025, 7:00:00 PM)

2.37

-0.05 (-2.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-25 2025-08-25
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap38.20M
Analysts84.44
Price Target4.08 (72.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.99%
Valuation
Industry RankSector Rank
PE 13.94
Fwd PE 7.93
P/S 0.91
P/FCF 9.31
P/OCF 9.09
P/B 3.84
P/tB 3.84
EV/EBITDA 7.06
EPS(TTM)0.17
EY7.17%
EPS(NY)0.3
Fwd EY12.6%
FCF(TTM)0.25
FCFY10.74%
OCF(TTM)0.26
OCFY11%
SpS2.61
BVpS0.62
TBVpS0.62
PEG (NY)0.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.64%
ROE 30.95%
ROCE 34.64%
ROIC 26.24%
ROICexc 59.83%
ROICexgc 59.83%
OM 10.65%
PM (TTM) 7.31%
GM 26.49%
FCFM 9.73%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexcg growth 3Y-30.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score6
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.91
Debt/EBITDA 0.6
Cap/Depr 18.68%
Cap/Sales 0.24%
Interest Coverage 250
Cash Conversion 83.68%
Profit Quality 133.16%
Current Ratio 1.91
Quick Ratio 1.66
Altman-Z 4.53
F-Score6
WACC7.49%
ROIC/WACC3.5
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.75%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-89.13%
EPS Next Y15.79%
EPS Next 2Y23.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-20.07%
Revenue Next Year7.05%
Revenue Next 2Y8.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.31%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year38.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.49%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y41.83%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%